FOR HEALTHCARE PROVIDERS
Live CME: Harnessing Approved and Emerging FcRn Blockers Across Subtypes in Antibody-Positive Generalized Myasthenia Gravis
Tuesday, September 30
11:00 AM ET / 8:00 AM PT
As part of our mission to empower patients and pursue a cure for MG, MGFA is proud to offer this free CME-accredited educational session on emerging FcRn blockers in antibody-positive generalized myasthenia gravis (gMG). Expert neurologists Dr. Gil Wolfe and Dr. Tuan Vu will provide real-world cases and insights to help providers navigate diagnostic testing, treatment selection, and emerging pharmacology in gMG.
Designed for neurologists and other HCPs, the program delivers real-world clinical guidance to help improve patient care today while driving awareness of new therapeutic possibilities on the horizon.
CME: 1.0 AMA PRA Category 1 Credits™
Presented in partnership with NORD and Medlive
Presenting Partners
